Patents
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
10/2008
10/01/2008CN101277956A Imidazo [1,2-A] pyridine having anti-cell-proliferation activity
10/01/2008CN101277955A Cyclic amine compound and pest control agent
10/01/2008CN101277951A 2-aminopyrimidine derivatives as modulators of the histamine H4 receptor activity
10/01/2008CN101277939A Acyclic ikur inhibitors
10/01/2008CN101277700A Pyrimidine compounds as serotonin receptor modulators
10/01/2008CN101274933A Dipyrene-3,4,6,7:12,13,15,16-octacarboxylic tertimide compound and preparation thereof
10/01/2008CN101274929A Thrombin receptor antagonists
10/01/2008CN100422183C Diaza-spiropiperidine derivatives as inhibitors of glycine transporter 1 and glycine transporter 2
10/01/2008CN100422182C Imidazopyridine-derivatives as inducible NO-synthase inhibitors
10/01/2008CN100422181C [1,8]naphthyridin-2-ones and related compounds for the treatment of schizophrenia
10/01/2008CN100422180C Amyloid plaque aggregation inhibitors and diagnostic imaging agents
10/01/2008CN100422175C 4-ring imidazole derivatives as modulators of metabotropic glutamate receptor-5
09/2008
09/30/2008US7429609 Pyrazole compound and medicinal composition containing the same
09/30/2008US7429597 Heterobicyclic compound such as quinazoline anticoagulants and factor X inhibitors
09/30/2008US7429591 Inhibiting the proteolytic activity of cathepsin S; 1-[4-(2-Amino-6-chloro-phenyl)-piperazin-1-yl]-3-[5-methanesulfonyl-3-(4-trifluoromethyl-phenyl)-4,5,6,7-tetrahydro-pyrazolo[4,3-c]pyridin-1-yl]-propan-2-ol; antiarthritic agent; autoimmune disease: lupus, rheumatoid arthritis, and asthma
09/30/2008US7429590 e.g. 2-(4-Fluorophenyl)-7-(1-methylpiperidin-4-yl)-3-(2-methylpyrimidin-4-yl)imidazo[1,2-a]-pyridine; protozoal diseases (toxoplasmosis, malaria, African typanosomiasis, Chagas disease, and opportunistic infections) in mammals and birds; controlling coccidiosis in poultry
09/30/2008US7429586 Non-imidazole aryloxyalkylamines
09/30/2008US7429579 antagonism/inhibition, of the D3 receptor; substance abuse.
09/30/2008US7429578 e.g. phenyl-3,4-dihydropyrrolo[4,3,2-de]isoquinolin-5-(1H)-one; anticarcinogenic agent; stroke, head trauma, and neurodegenerative disease; potentiating cytotoxicity of a DNA-damaging cytotoxic agent or ionizing radiation
09/30/2008CA2417417C Method for recovery of copper from sulfidic ore materials using super-fine grinding and medium temperature pressure leaching
09/30/2008CA2263425C Pharmaceutical agent containing rho kinase inhibitor
09/30/2008CA2214219C Pyrido[2,3-d]pyrimidines for inhibiting protein tyrosine kinase mediated cellular proliferation
09/25/2008WO2008115820A1 Combination of a narcotic and a non-narcotic analgesic
09/25/2008WO2008115098A2 Substituted 2,3,4,5-tetrahydro-1h-pyrido[4,3-b]indoles, methods for the production and the use thereof
09/25/2008WO2008114691A1 Process for production of mirtazapine
09/25/2008WO2008114690A1 Compound wherein substituted bipyridyl group is connected with pyridoindole ring structure through phenylene group, and organic electroluminescent device
09/25/2008WO2008113965A1 Indolizine acetic acid derivatives as crth2 antagonists
09/25/2008WO2008113856A1 Pyrazolo pyridine derivatives as nadph oxidase inhibitors
09/25/2008WO2008113753A1 Method for the production of rylene tetracarboxylic acid diimides the imide nitrogens of which carry hydrogen atoms and the use thereof
09/25/2008WO2008113711A1 Substituted pyrimidodiazepines useful as plk1 inhibitors
09/25/2008WO2008113558A1 Amino-naphthyridine derivatives
09/25/2008WO2008113452A1 Substituted tetrahydropyrroloquinolines
09/25/2008WO2008113255A1 Benzamide derivatives with anti-proliferative activity, pharmaceutical preparations thereof
09/25/2008WO2008094574A3 Furanone compounds and methods of making and using the same
09/25/2008WO2008094556A3 Imidazolone compounds as tgf-beta family type i receptors, alk5 and/or alk4 antagonists
09/25/2008WO2008077810A3 Spiro-piperidine derivatives
09/25/2008WO2008046919A3 Heterocyclic compounds and their use as glycogen synthase kinase 3 inhibitors
09/25/2008WO2008021038B1 Pyridobenzazepine compounds and methods for inhibiting mitotic progression
09/25/2008WO2007146349A3 Cgrp receptor antagonists
09/25/2008US20080234314 2-(6-bromobenzo[d][1,3]dioxol-5-ylthio)-1-(pent-4-ynyl)-1H-imidazo [4,5-c]pyridin-4-amine; cancer, an autoimmune disease, or a neurodegenerative disease; ubiquitous chaperone protein inhibitors
09/25/2008US20080234313 Novel inhibitors
09/25/2008US20080234310 Administering cis(+-) 2,8-dimethyl-2,3,4,4a,5,9b-hexahydro-1H-pyrido[4,3-b]indole; prolonging lifespan, improving quality of life
09/25/2008US20080234306 (S)-17-Cyclopropylmethyl-4,5 alpha -epoxy-3,14-dihydroxymorphinan N-oxide and an opioid agonist; significant mu-opioid receptor antagonistic activity; reducing opioid side-effects, dysphoria, pruritis, urinary retention, nausea, emesis
09/25/2008US20080234300 Pyrimido[5,4-c] Quinoline-2, 4-Diamine Derivatives and Methods of Use Thereof
09/25/2008US20080234277 Novel aza-pyridopyrimidinone derivatives
09/25/2008US20080234276 Heterocyclic Triazines as Hypoxic Selective Protein Kinase Inhibitors
09/25/2008US20080234266 Squaric Acid Derivatives II
09/25/2008US20080234261 Preparation of 1,6-Disubstituted Azabenzimidazoles as Kinase Inhibitors
09/25/2008US20080234254 anticarcinogenic agents for treating leukaemia, non-small cell lung cancers, colonic cancers, breast cancers, ovarian cancers, renal cancers and melanoma; in vivo hydrolysable ester or amide; N-(2-amino-phenyl)-4-[1-(3,4-dihydroisoquinolin-2(1H)-ylmethyl)vinyl]benzamide; solid phase synthesis
09/25/2008US20080234252 2-[4-(4-Chlorophenyl)-5-(methoxymethyl)-4H-1,2,4-triazol-3-yl]isoindoline; vasopressin antagonists; dysmenorrhea, Alzheimer's disease, anorexia nervosa, anxiety, anxiety disorder, asthma, atherosclerosis, autism, cardiovascular disease
09/25/2008DE102007013856A1 Substituierte Tetrahydropyrrolochinoline Substituted Tetrahydropyrrolochinoline
09/25/2008CA2682195A1 Aminopyrimidines useful as kinase inhibitors
09/25/2008CA2681516A1 Compounds useful as inhibitors of janus kinases
09/25/2008CA2681409A1 Indolizine acetic acid derivatives as crth2 antagonists
09/25/2008CA2681260A1 Substituted tetrahydropyrroloquinolines
09/25/2008CA2680757A1 Substituted pyrimidodiazepines useful as plk1 inhibitors
09/25/2008CA2676954A1 Pyrazolo pyridine derivatives as nadph oxidase inhibitors
09/25/2008CA2664286A1 Process for production of mirtazapine
09/24/2008EP1972629A1 New imidazolo-heteroaryl derivatives with antibacterial properties
09/24/2008EP1972628A1 Indolizines and aza-analog derivatives thereof as CNS active compounds
09/24/2008EP1972627A1 Amino-napthyridine derivatives
09/24/2008EP1971611A1 Anti-viral compounds
09/24/2008EP1971608A1 Spiroketals
09/24/2008EP1971606A2 2-pyrimidinyl pyrazolopyridine erbb kinase inhibitors
09/24/2008EP1971605A1 Pyrrolo [2 , 3-b] pyridine derivatives as h3 receptor modulators
09/24/2008EP1971604A2 Pyrrolo-pyridine derivatives for the treatment of cancer diseases
09/24/2008EP1971602A2 Niacin receptor agonists, compositions containing such compounds and methods of treatment
09/24/2008EP1971601A2 N4-phenyl-quinazoline-4 -amine derivatives and related compounds as erbb type i receptor tyrosine kinase inhibitors for the treatment of hyperproliferative diseases
09/24/2008EP1971599A1 Antiviral 2-carboxy-thiophene compounds
09/24/2008EP1971596A2 Fused heterocyclic compounds and their use as mineralocorticoid receptor ligands
09/24/2008EP1899334B1 Naphthyridine compounds
09/24/2008EP1496836B1 N-(substituted benzyl)-8-hydroxy-1,6-naphthyridine-7- carboxamides useful as hiv integrase inhibitors
09/24/2008EP1465877B1 Positive-working photoimageable bottom antireflective coating
09/24/2008EP1322650B1 Farnesyl transferase inhibiting 6-heterocyclylmethyl quinoline and quinazoline derivatives
09/24/2008CN101273046A Indol-3-yl-carbonyl-azaspiro derivatives as vasopressin receptor antagonists
09/24/2008CN101273040A Oxadiazolyl pyrazolo-pyrimidines as MGLUR2 antagonists
09/24/2008CN101273039A Heterobicyclic compounds useful as p38 kinase inhibiting agents
09/24/2008CN101272785A Tetrahydro- beta-carbolin-sulfonamide derivatives as 5-HT6 ligands
09/24/2008CN101270120A Novel tricyclic derivatives, method for preparing same and pharmaceutical compositions containing same
09/24/2008CN101270119A Technique for purifying spherosinin from leguminosae pointvetch or milk vetch
09/24/2008CN101270118A Technique for spherosinin purification with continuous column chromatography
09/24/2008CN101270087A Isoquinoline derivatives and methods of use thereof
09/24/2008CN100420687C Pyridino [2, 3-D] pyrimidine derivatives as selective KDR and FGFR inhibitors
09/24/2008CN100420674C Process for preparing phencynonate optical isomer
09/23/2008US7427682 Indole derivatives as selective androgen receptor modulators (SARMS)
09/23/2008US7427681 Anticancer agents; antidiabetic agents; Alzheimer's disease
09/23/2008US7427631 especially as inhibitors of MMP12
09/23/2008US7427630 1-{1-[1-(4-Methoxy-2-methylphenyl)-6-methyl-2,3-dihydro-1H-pyrrolo[2,3-b]pyridin-4-yl]-1H-pyrazol-3-yl}imidazolidin-2-one; potent; to treat central nervous system disorders; antidepressants; Anxiolytic agents; mood disorders; anagesics; gastrointestinal disorders like irritable bowel syndrome
09/23/2008US7427625 Substituted thiatriazaacenaphthylene-6-carbonitrile kinase inhibitors
09/23/2008US7427617 e.g. 2-[1-(2-Fluorobenzyl)-1H-indazol-3-yl]-5-(3-oxa-9-azabicyclo[3.3.1]non-9-yl)-4pyrimidinylamine; soluble guanylate cyclase stimulant; neurodegenerative diseases, cognition activator; Alhzeimer's, Parkinson's disease, Pick's syndrome, multiple sclerosis, HIV dementia, schizophrenia
09/23/2008US7427613 7-aryl-3,9-diazabicyclo(3.3.1)non-6-ene derivatives and their use as renin inhibitors in the treatment of hypertension, cardiovascular or renal diseases
09/23/2008CA2480800C Inhibitors of akt activity
09/23/2008CA2432872C Pyrazole compounds useful as protein kinase inhibitors
09/23/2008CA2395541C New substituted piperidines, pharmaceutical compositions containing these compounds and processes for preparing them
09/23/2008CA2337825C Disubstituted bicyclic heterocycles, the preparation thereof and their use as pharmaceutical compositions
09/18/2008WO2008112734A1 Heterocyclic-carbonyl-diazabicycloalkanes as modulators of the neuronal nicotinic acetylcholine alpha 4 beta 2, subtype receptor for the treatment of cns related disorders
09/18/2008WO2008112646A1 Aminopyridines useful as inhibitors of protein kinases
09/18/2008WO2008112642A1 Aminopyrimidines useful as inhibitors of protein kinases
09/18/2008WO2008112280A1 Substituted heterocycle fused gamma-carbolines synthesis
09/18/2008WO2008111604A1 Novel pyrimidine compound having benzyl(heterocyclicmethyl)amine structure and pharmaceutical product containing the same